Journal September 25, 2026 6 min read

Common Misconceptions About Insulin Sensitivity: A Research-Supply Perspective

Insulin sensitivity is not a single switch. This research-supply overview examines what the evidence says about DPP-4 inhibition, avocado consumption, spexin and galanin, eGDR, sulforaphane, mitochondria-targeted agents,

peptides-pro Editorial

What insulin sensitivity actually is

Insulin sensitivity is the efficiency with which insulin elicits its metabolic effects, principally glucose uptake in skeletal muscle and adipose tissue and suppression of hepatic glucose output. It is not a single molecule or a single receptor; it is a physiological property of multiple tissues, and it is measured in research by surrogate indices such as the estimated glucose disposal rate (eGDR) rather than by one universal assay. The evidence block for this page does not supply a sequence, formula, or molecular weight for insulin sensitivity itself, because it is a trait rather than a compound.

The work summarised here centres on the insulin receptor and its downstream phosphatidylinositol 3-kinase signalling axis, together with the incretin axis (GLP-1 and GIP) that modulates insulin secretion and, indirectly, insulin action.

Research Studies

Vildagliptin and insulin sensitivity in polycystic ovary syndrome

Polycystic ovary syndrome (PCOS) is an endocrine and metabolic disorder characterised by hyperandrogenism, ovulatory dysfunction, and polycystic ovarian morphology, with insulin resistance playing a central pathophysiological role. Hyperinsulinaemia can enhance ovarian androgen production and reduce hepatic sex hormone-binding globulin synthesis, aggravating hyperandrogenism and reproductive abnormalities. Vildagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, enhances endogenous incretin activity and may improve insulin sensitivity and glucose homeostasis. Emerging evidence suggests DPP-4 inhibition may also influence body weight, androgen excess, and inflammation [1].

Avocado consumption and brain insulin sensitivity in pre-diabetic adults

A randomised crossover intervention is assessing the effect of 12 weeks of daily avocado consumption on cerebral blood flow and markers of cardio- and vascular health in the periphery and the brain in pre-diabetic individuals with overweight or obesity. A secondary objective is to assess effects on brain insulin sensitivity after intranasal insulin delivery, vascular function, metabolic markers, cognition, and psychological well-being. Thirty-four men and women aged 40–75 years are to participate [2].

Spexin and galanin in type 2 diabetes mellitus

Spexin and galanin are neuropeptides involved in glucose homeostasis, insulin sensitivity, appetite, and energy metabolism. A systematic review and meta-analysis synthesised evidence on circulating spexin and galanin concentrations in patients with type 2 diabetes mellitus (T2DM). Observational studies reporting circulating spexin and/or galanin levels in adults with T2DM and non-diabetic controls were included, and random-effects meta-analyses calculated pooled standardised mean differences with 95% confidence intervals [3].

Estimated glucose disposal rate and self-reported endometrial cancer

Given accumulating data implicating insulin resistance in endometrial carcinogenesis, a cross-sectional study evaluated whether eGDR, a feasible non-invasive insulin resistance metric, is associated with self-reported endometrial cancer. The analytical sample consisted of 31,666 female NHANES respondents (1999–2018), including 248 endometrial cancer cases and 31,418 cancer-free comparators. Propensity score matching (1:1) controlled for baseline imbalances. eGDR was significantly lower in the endometrial cancer group (6.84 ± 2.76) than in the control group (7.51 ± 2.66) (P = 0.004) [4].

eGDR in the NHANES 1999–2018 sample [4]

Group	n	eGDR (mean ± SD)
Self-reported endometrial cancer	248	6.84 ± 2.76
Cancer-free comparators	31,418	7.51 ± 2.66

Sulforaphane and broccoli-derived preparations in obesity-related metabolic dysfunction

Obesity is characterised by adipose tissue dysfunction, insulin resistance, chronic low-grade inflammation, oxidative stress, mitochondrial dysfunction, and increased cardiometabolic risk. Sulforaphane, a bioactive isothiocyanate derived primarily from broccoli and other cruciferous vegetables, has attracted attention for its antioxidant, anti-inflammatory, and metabolic regulatory properties. A narrative review critically evaluates this evidence in the context of obesity and obesity-related metabolic dysfunction [5].

MitoQ and SS-31 in aged female mice with MASLD

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a major cause of cirrhosis, liver cancer, and cardiovascular disease, with early mitochondrial dysfunction driving lipid imbalance, inflammation, and fibrosis. A study compared the mitochondria-targeted agents MitoQ and SS-31 for effects on mitochondrial function, oxidative stress, apoptosis, and inflammation in aged, nutritionally stressed mice with MASLD. Aged female C57BL/6 mice (12–14 months) were fed a high-fat, high-fructose diet for 16 weeks and randomised into four groups: control diet, MASLD, MASLD + MitoQ (25 mg/kg/day), and further arms as described in the source [6]. This evidence is animal-only.

Estrogen and the response of glycaemic control to exercise training

Previous research has found that males and females respond differently to exercise training, particularly with respect to improvements in blood sugar control and immune system health. Insulin resistance, which can lead to type 2 diabetes and other health problems, affects millions of Canadians, and people with insulin resistance often have higher inflammation. Exercise is known to improve insulin resistance and reduce inflammation, but females appear to benefit less from exercise than males. Investigators believe this difference may be due to estrogen, a hormone that helps regulate blood sugar in non-exercising conditions and reduce inflammation [7].

Sleep, muscle metabolism, and Alzheimer's disease vulnerability

Sleep disruption is a hallmark of aging and a plausible driver of Alzheimer's disease vulnerability. Reduced slow-wave sleep, increased fragmentation, and circadian instability may facilitate amyloid-β accumulation, tau propagation, neuroinflammation, oxidative stress, and impaired glymphatic clearance. A review advances a sleep–muscle–brain framework in which sarcopenia, sarcopenic obesity, and insulin resistance are conceptualised as modifiable muscle-metabolic conditions that may bias sleep continuity and shape the biological impact of sleep disruption [8].

Hypothalamic autophagy, PD-L2, proinsulin processing, and polyendocrine metabolic ovarian syndrome

Additional reference material supports the broader picture. Within the arcuate nucleus, autophagy exerts divergent metabolic effects in the two principal appetite-regulating neuronal populations, and obesity is increasingly recognised as a disorder involving impaired central endocrine regulation in which hypothalamic nutrient sensing, leptin responsiveness, and intracellular quality control are intertwined [9]. A cross-sectional study evaluated bone mineral density, body composition, sex hormone levels, and insulin sensitivity in women with Polyendocrine Metabolic Ovarian Syndrome compared with women without the syndrome [10]. Separately, blocking PD-L2 has been reported to prevent senescent cell accumulation and age-related dysfunction, including metabolic dysfunction and impaired fitness [11]. In type 2 diabetes, glucose-lowering may be mediated by improved proinsulin processing without better β-cell compensation, with an elevated fasting serum proinsulin-to-C-peptide ratio marking β-cell stress [12].

If you are reading this for personal health reasons

The materials described on this page are sold for laboratory research only, and nothing here is medical advice. We do not provide dosing, administration, or clinical guidance for any compound. Anyone considering a compound for their own use should speak to a licensed clinician.